Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice

Cancer: Principles and Practice of Oncology.

(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,524

Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme

Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., & Honjo, T. (2000) · Cell · doi:10.1016/s0092-8674(00)00078-7 · Cited by 3,475

Cancer: Principles and Practice of Oncology.

(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-506_5 · Cited by 1,913

Clonal selection and learning in the antibody system

Rajewsky, K. (1996) · Nature · doi:10.1038/381751a0 · Cited by 1,701

Blimp-1 Orchestrates Plasma Cell Differentiation by Extinguishing the Mature B Cell Gene Expression Program

Shaffer, A. L., Lin, K., Kuo, T. C., Yu, X., Hurt, E. M., Rosenwald, A., Giltnane, J. M., Yang, L., Zhao, H., Calame, K. L., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00335-7 · Cited by 1,048

Control of Inflammation, Cytokine Expression, and Germinal Center Formation by BCL-6

Dent, A. L., Shaffer, A. L., Yu, X., Allman, D., & Staudt, L. M. (1997) · Science · doi:10.1126/science.276.5312.589 · Cited by 950

BCL-6 Represses Genes that Function in Lymphocyte Differentiation, Inflammation, and Cell Cycle Control

Shaffer, A. L., Yu, X., He, Y., Boldrick, J. C., Chan, E. P., & Staudt, L. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)00020-0 · Cited by 879

The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation

Ye, B. H., Cattoretti, G., Shen, Q. “., Zhang, J., Hawe, N., de Waard, R., Leung, C. C., Nouri-Shirazi, M. A., Orazi, A., Chaganti, R. S. K., et al. (1997) · Nature Genetics · doi:10.1038/ng0697-161 · Cited by 820

Cellular Origin of Human B-Cell Lymphomas

Küppers, R., Klein, U., Hansmann, M., & Rajewsky, K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911113412007 · Cited by 715

The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells

Phan, R. T., & Dalla‐Favera, R. (2004) · Nature · doi:10.1038/nature03147 · Cited by 705

Development of a contacting transwell co-culture system for the in vitro propagation of primary central nervous system lymphoma

Nishi, M., Tateishi, K., Jeremiah, S. S., Ino, Y., Nakai, Y., Hatayama, Y., Yamaoka, Y., Mihana, Y., Miyakawa, K., Kimura, H., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1275519 · Cited by 3

Bcl-6-dependent risk stratification by nuclear expression of Peli1 in diffuse large B-cell lymphoma

Lee, K. R., Lee, J., Lee, J. S., & Paik, J. H. (2022) · Journal of Cancer · doi:10.7150/jca.67569 · Cited by 3

Follicular lymphoma: stillSix characters in search of an author?

Piccaluga, P. P., Pileri, S. A., Agostinelli, C., Klapper, W., & Lennert, K. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2011.575493 · Cited by 3

8. Diffuse large B-cell lymphoma

Pasqualucci, L. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4313-1_9 · Cited by 3

Pathology and Molecular Pathogenesis of DLBCL and Related Entities

Pasqualucci, L., & Ott, G. (2018) · Methods in molecular biology · doi:10.1007/978-3-030-00362-3_2 · Cited by 4

An Orally Available Small Molecule BCL6 Inhibitor Effectively Suppresses Diffuse Large B Cell Lymphoma Cells Growth in Vitro and in VivoPreprint

Xing, Y., Guo, W., Wu, M., Xie, J., Huang, D., Hu, P., Zhou, M., Zhang, L., Zhang, Q., Wang, P., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-820765/v1 · Cited by 3

Key Functions of the Transcription Factor BCL6 During T-Cell Differentiation

Konstantakopoulou, C., & Verykokakis, M. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-62731-6_4 · Cited by 2

Immunoglobulin Gene Rearrangements, Oncogenic Translocations, B-Cell Receptor Signaling, and B Lymphomagenesis

Gururajan, M., & Bondada, S. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0711-0_17 · Cited by 2

Pathologie moléculaire des lymphomes diffus à grandes cellules B : intérêt diagnostique et pronostique pour l’histopathologiste

Molina, T. J., Tourneau, A. L., Damotte, D., Diebold, J., & Audouin, J. (2011) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(11)70862-0 · Cited by 2

Oct2, BCL6, IRF8, OCAB and PU.1 in the Assessment of Prognosis in Diffuse Large B cell Lymphoma Patients

Bilbao, E. A. R., & Knott, M. E. (2016) · Journal of Molecular Biomarkers & Diagnosis · doi:10.4172/2155-9929.1000276 · Cited by 2

FBXO11: a novel germinal center B-cell regulator?

Elenitoba‐Johnson, K. S. J. (2016) · Blood · doi:10.1182/blood-2016-06-717496 · Cited by 2

Combinatorial Tethering: A Novel Mode to Recruit Non-canonical PRC1 for Normal and Malignant GC B Cell Development

Zeisig, B. B., & So, C. W. E. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.07.014 · Cited by 2

Molecular Pathogenesis of B Cell Lymphomas

Dalla‐Favera, R., & Pasqualucci, L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397933-9.00022-9 · Cited by 2

Structural Vulnerabilities in DLBCL for Enhanced Treatment Strategies

Cristaldi, V., & Lund, A. W. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-1956 · Cited by 1

Genetic Mouse Models of Lymphomas

Knittel, G., & Reinhardt, H. C. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-4188-0_18 · Cited by 1

Discovery of pyrrolopyrimidinone inhibitors of the BCL6-SMRT corepressor interaction

Watson, I. D. G., Morin, J. A., Subramanian, P. R., Chau, A. M., Prakesch, M. A., Wilson, B. J., Morshed, M. M., Joseph, B. B., Uehling, D., Poda, G. I., et al. (2026) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2026.118575 · Cited by 1

DNA secondary structures in BCL2 and MYC elicit activation-induced cytidine deaminase binding and activity

McCrury, M., Sanchez, A., Mangold, R., Spears, T. J., Doshier, C., Buisson, R., Miah, M., Akdeniz, D., & Kendrick, S. L. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag203 · Cited by 1

Constitutive DUSP2 expression enhances lymphoid cell proliferation by activating CDK1 and promotes lymphomagenesis

Yu, Q., Panaampon, J., Chapuy, B., Zhang, X., Zhao, X., Wang, Z., Zhang, P., Payungwong, T., Zhang, A., Ke, Q., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117652 · Cited by 1

New Therapeutic Frontiers for Childhood Non-Hodgkin Lymphoma

Lim, M. S., & Cairo, M. S. (2010) · Springer eBooks · doi:10.1007/978-0-387-69062-9_10 · Cited by 1

Multiple cytokine- and multiple cytokine receptor-expressing triple-hit B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt’s lymphoma

Nakayama, S., Yokote, T., Iwaki, K., Tsuji, M., & Hanafusa, T. (2013) · Pathology · doi:10.1097/pat.0b013e3283634dec · Cited by 1

Lymphoma/Myeloma

Tonon, G., & Anderson, K. C. (2008) · Elsevier eBooks · doi:10.1016/b978-141603703-3.10026-3 · Cited by 1

Regulation of BCL6: p38 MAPK signalling and CTCF transcriptional regulation converge at exon 1

Batlle, A. (2010) · doi:10.25560/6093 · Cited by 1

Molekularbiologie maligner Lymphome für den Nicht-Spezialisten

Novak, U. (2010) · Therapeutische Umschau · doi:10.1024/0040-5930/a000085 · Cited by 1

Report on the 1st International Workshop of the German Competence Network Malignant Lymphomas

Ré, D., Elter, T., & Hallek, M. J. (2007) · Oncology Research and Treatment · doi:10.1159/000100909 · Cited by 1

vitro and in vivo A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in

Dowdy, S. F., Leandro, M., Cerchietti, C., Yang, S. N., Shaknovich, R., Hatzi, K., & Polo, J. M. (2010) · Cited by 1

DREAM2 Challenge

Lee, W. H., Narang, V., Xu, H., Lin, F., Chin, K. C., & Sung, W.-K. K. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03755.x · Cited by 1

Mouse Hematolymphoid Neoplasms

Rehg, J. E. (2021) · doi:10.1002/9781119624608.ch8 · Cited by 1

Leveraging the BAF chromatin remodeling complex for targeted transcriptional rewiring in cancerPreprint

Segal, D., Kainacher, L., Muffel, T., Geiger, T. M., Lechner, S., Mavridi, D., Balourdas, D.-I., Nelles, M., Schätz, C., Knapp, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.30.715217 · Cited by 1

Targeted Therapy in Lymphoma

Wedgwood, A., & Younes, A. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-424-1_8 · Cited by 1

Antagonistic Pleiotropy: The Role of Smurf2 in Cancer and Aging: A Dissertation

Ramkumar, C. (2012) · eScholarship@UMassChan · doi:10.13028/b1er-s046

Immunoglobulin gene alterations in the progression of B cell lymphomas

Smit, L. A. (2008) · UvA-DARE (University of Amsterdam)

The role of the transcriptional corepressor Bcor in embryonic stem cells and mouse development.

Wamstad, J. A. (2009) · University of Minnesota Digital Conservancy (University of Minnesota)

Preclinical Modeling in Lymphoid Malignancies

Dawar, R., & Hernandez‐Ilizaliturri, F. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5851-7_6

A functional role for transfer RNA-derived microRNAs in human B cells

Maute, R. L. (2013) · doi:10.7916/d87d327f

Novel pathogenetic mechanisms and therapeutic targets in B cell lymphomas

Dalla‐Favera, R. (2009) · Hematology Meeting Reports · doi:10.4081/hmr.v2i7.398

B Cell Growth, Differentiation and Malignancies

Tao, J., & Hu, C. A. (2012) · Springer eBooks · doi:10.1007/978-94-007-5028-9_1

Functional Analysis of Ing1 and Ing4 in Cell Growth and Tumorigenesis: a Dissertation

Coles, A. H. (2008) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/pr7a-s521

Biological Pathways in B-cell Non-Hodgkin's Lymphoma

Aggarwal, M. (2009) · Figshare

Closing the loop: p53-BCL6 feedback

Lossos, I. S. (2006) · Blood · doi:10.1182/blood-2005-11-4718

Novel Roles of Ataxia Telangiectasia Mutated (ATM) in DNA Repair and Tumor Suppression

Yamamoto, K. (2015) · doi:10.7916/d8x34x6t

SVEUILIŠTE U ZAGREBU

Fakultet, M. (2006)

Title Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis( Main article )

Asoke, K., & Casola, S. S. (2013)

Pathogenetic mechanisms and therapeutic targets in diffuse large B-cell lymphomas characterized by constitutive tonic B-cell receptor activity and BCL6 transcriptional program: from DNA microarrays to rational therapy Mechanizmy patogenetyczne i cele terapeutyczne w chłoniaku rozlanym z dużych komórek B zależne od konstytutywnej aktywności tonicznej receptora B-komórkowego i programu transkrypcyjnego BCL6: od mikromacierzy DNA do racjonalnego leczenia

Faber, D. (2009)

Untersuchungen zum Einfluss der Zytokine CD40L, IL-6 und IL-10 auf die terminale Differenzierung der B-Lymphozyten des Haushuhns

München, L.-M.-U. (2009)

Molecular pathology of lymphoma

Schneider, C., Pasqualucci, L., & Dalla‐Favera, R. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139046947.069

Development Of A Novel Class Of Chemicals For Labeling Abasic Sites In Cellular Dna And Killing Cancer Cells

Wei, S. (2016) · Human Biology

Characterization of the MIR23A Cluster in Diffuse Large B Cell Lymphoma

Freytag, N. V. (2017) · doi:10.53846/goediss-6430

BCL6 Translocations in B-Cell Tumors

Ohno, H. (2015) · Springer eBooks · doi:10.1007/978-3-642-27841-9_567-2

Faculty Opinions recommendation of MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma.

Dimitrova, P. A., & Shivarov, V. S. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718085329.793486454

BCL6 Translocations in B-Cell Tumors

Ohno, H. (2011) · Springer eBooks · doi:10.1007/978-3-642-16483-5_567

Faculty Opinions recommendation of Signatures of murine B-cell development implicate Yy1 as a regulator of the germinal center-specific program.

Tsubata, T. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.8544961.9025060

BCL6 Translocations in B-Cell Tumors

Ohno, H. (2017) · Springer eBooks · doi:10.1007/978-3-662-46875-3_567

Faculty Opinions recommendation of A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo.

Morin, P. J., & Yan, B. (2010) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.3334971.3023070

Data from Targeted Disruption of the S1P2 Sphingosine 1-Phosphate Receptor Gene Leads to Diffuse Large B-Cell Lymphoma Formation

Cattoretti, G., Mandelbaum, J., Lee, N., Chaves, A. H., Mahler, A. M., Chadburn, A., Dalla‐Favera, R., Pasqualucci, L., & MacLennan, A. J. (2023) · doi:10.1158/0008-5472.c.6499557.v1

Data from Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma

Hoppe, M. M., Jaynes, P. W., Shuangyi, F., Peng, Y., Sridhar, S., Hoang, P. M., Liu, C. X., Mel, S. D., Poon, L. M., Chan, E. H. L., et al. (2023) · doi:10.1158/2159-8290.c.6605362

Data from Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma

Hoppe, M. M., Jaynes, P. W., Shuangyi, F., Peng, Y., Sridhar, S., Hoang, P. M., Liu, C. X., Mel, S. D., Poon, L. M., Chan, E. H. L., et al. (2023) · doi:10.1158/2159-8290.c.6605362.v2

Exome and targeted sequencing in clinical oncology- Diffuse large B-cell lymphoma as a model

Lu, T., & Young, K. H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824010-6.00045-9

Molekulare Klassifizierung und Therapien des diffusen großzelligen B-Zell-Lymphoms

Shimkus, G., & Nonaka, T. (2023) · Kompass Onkologie · doi:10.1159/000531124

An orally available small molecule BCL6 inhibitor effectively suppresses diffuse large B cell lymphoma cells growth in vitro and in vivoPreprint

Xing, Y., Guo, W., Wu, M. Y., Xie, J., Huang, D., Hu, P., Zhou, M., Zhang, Q., Wang, P., Wang, X., et al. (2024) · doi:10.22541/au.170667314.42007148/v1

Molecular Pathogenesis of B-Cell Lymphomas

Pasqualucci, L., Simone, P. D., & Dalla‐Favera, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95895-0.00020-9

Investigação do envolvimento do baço na imunopatogênese da febre amarela

Marmorato, M. P. (2023) · doi:10.11606/t.5.2023.tde-29022024-122302

Selective deletion of E3 ubiquitin ligase FBW7 in VE-cadherin-positive cells instigates diffuse large B-cell lymphoma in mice in vivo

Cai, Z., You, S., Liu, Z., Song, P., Zhao, F., An, J., Ding, Y., He, B., & Zou, M. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06597-7

Mechanisms of the role of proto-oncogene activation in promoting malignant transformation of mature B cells.

Zhou, R., Guo, J., Feng, X., & Zhou, W. (2024) · PubMed Central · doi:10.11817/j.issn.1672-7347.2024.230304

Structure-based discovery of sulfamoyl-ethyl-4-oxo-3,4-dihydro-7H-pyrrolo[2,3-d]pyrimidine amides and sulfonamides as potent B-Cell Lymphoma 6 (BCL6)-BTB inhibitors

Mamai, A., Morshed, M. M., Prakesch, M. A., Poda, G. I., Pandiaraju, S., Chau, A. M., Watson, I. D. G., Joseph, B., Wilson, B., Morin, J. A., et al. (2025) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2025.130471

Additional file 3 of The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma

Kang, J. H., Lee, S. H., Lee, J., Choi, M., Cho, J., Kim, S. J., Kim, W. S., Ko, Y. H., & Yoo, H. Y. (2021) · Figshare · doi:10.6084/m9.figshare.13612563

Additional file 4 of The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma

Kang, J. H., Lee, S. H., Lee, J., Choi, M., Cho, J., Kim, S. J., Kim, W. S., Ko, Y. H., & Yoo, H. Y. (2021) · Figshare · doi:10.6084/m9.figshare.13612566

Additional file 5 of The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma

Kang, J. H., Lee, S. H., Lee, J., Choi, M., Cho, J., Kim, S. J., Kim, W. S., Ko, Y. H., & Yoo, H. Y. (2021) · Figshare · doi:10.6084/m9.figshare.13612569

Additional file 1 of The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma

Kang, J. H., Lee, S. H., Lee, J., Choi, M., Cho, J., Kim, S. J., Kim, W. S., Ko, Y. H., & Yoo, H. Y. (2021) · Figshare · doi:10.6084/m9.figshare.13612557

Additional file 6 of The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma

Kang, J. H., Lee, S. H., Lee, J., Choi, M., Cho, J., Kim, S. J., Kim, W. S., Ko, Y. H., & Yoo, H. Y. (2021) · Figshare · doi:10.6084/m9.figshare.13612572

Additional file 2 of The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma

Kang, J. H., Lee, S. H., Lee, J., Choi, M., Cho, J., Kim, S. J., Kim, W. S., Ko, Y. H., & Yoo, H. Y. (2021) · Figshare · doi:10.6084/m9.figshare.13612560

Caractérisation moléculaire des cellules de lymphome folliculaire et de leur micro-environnement et incidence clinique

Huet, S. (2015) · theses.fr (ABES) · doi:10.70675/d46388a0z0957z453dzb3d4z35a4d2d3000c

Rôle des protéines Orai1 et STIM1 dans les lymphomes B non-Hodgkiniens, établissement d'un modèle d'étude en 3D.

Latour, S. (2018) · theses.fr (ABES) · doi:10.70675/b4d72b4fz22d7z4979za0d7z943a0cb1be1e

Les lymphomes B diffus à grandes cellules de type activé : rôle de NF-κB et c-Myc.

Arnaud, N. (2017) · theses.fr (ABES) · doi:10.70675/f86c2a1cz9979z400dz8e23ze8914714a1a8

Anomalies moléculaires dans la macroglobulinémie de Waldenström : identification d’une mutation somatique récurrente dans le gène codant pour le facteur de transcription SPI1/PU.1 et description de ses conséquences fonctionnelles

Roos‐Weil, D. (2018) · theses.fr (ABES) · doi:10.70675/1030cb13z12b8z4f7cz8f8az165206a6209a

The Growth Supporting Role of ZDHHC11 Is Linked to the MEF2B – BCL6 Regulatory Circuit in Burkitt Lymphoma

Ziel-Swier, L. J. Y. M., Rassek, K., Liu, Y., Seitz, A., Koerts, J. A., de Jong, D., Rutgers, B., Kompaniiets, A., Przybył, J., Chamuleau, M. E. D., et al. (2026) · International Journal of Cancer · doi:10.1002/ijc.70506

A lipid nanoparticle-based peptide-proteolysis-targeting chimera degrades BCL6 for diffuse large B-cell lymphoma treatment

Liu, S. H., Gao, X., Ye, X., Chen, Y., Wang, K. J., Liu, Y., Wang, S., shen, H., Shen, H., Li, R. J., et al. (2026) · Discover Oncology · doi:10.1007/s12672-026-05153-3

Regulatory factor X 7 limits Myc activity during B cell activation and suppresses Myc-dependent lymphomagenesis

Fischer, B. A., Khameneh, H. J., Guerra, J., Zenobi, A., Ciorciari, J., Buzzago, I., Merli, M. S., Said, M., Ventura, P., Pfister, A., et al. (2026) · Nature Immunology · doi:10.1038/s41590-026-02526-2

Mouse models of B cell lymphomas on the basis of genetic features

Yuan, M., & Wang, J. Q. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1870989

Recent Advances in Chronic Myeloid Leukaemia (CML): Emerging Molecular and Immunotherapeutic Targets

Dai, J., Zheng, P., Liu, J., Cheng, L., Zheng, X. W., Chen, L., Jiang, J., & Zheng, Z. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl48912

BCOR Biology in Development and Cancer

Royston, H. N., Taddia, A., Santori, F. R., Ivanova, N., & Funato, K. (2026) · Cells · doi:10.3390/cells15201856

BindingDB Entry 11791: Discovery of OICR12694: A Novel, Potent, Selective, and Orally Bioavailable BCL6 BTB Inhibitor.

BindingDB (2024) · UC San Diego · doi:10.7270/q2m049mh

BindingDB Entry 50019677: Discovery of an

BindingDB (2024) · UC San Diego · doi:10.7270/q2ms3z53

BindingDB Entry 50022214: Discovery of novel BCL6-Targeting PROTACs with effective antitumor activities against DLBCL in vitro and in vivo.

BindingDB (2025) · UC San Diego · doi:10.7270/q24q80p3

BindingDB Entry 50010780: Rationally Designed Covalent BCL6 Inhibitor That Targets a Tyrosine Residue in the Homodimer Interface.

BindingDB (2021) · UC San Diego · doi:10.7270/q25t3q1q

BindingDB Entry 50000029: Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors.

BindingDB (2019) · UC San Diego · doi:10.7270/q2zw1p1c

BindingDB Entry 50017482: B-cell Lymphoma 6 Inhibitors: Current Advances and Prospects of Drug Development for Diffuse Large B-cell Lymphomas.

BindingDB (2023) · UC San Diego · doi:10.7270/q2jm2fpw

An investigation of the regulation of BLIMP1 by the epstein-barr virus in B cells

Vrzalikova, K. (2011) · University of Birmingham Institutional Research Archive (University of Birmingham)

The BCL6 Oncogene Drives an Epigenomic Program Linking Stem Cells to the Pathogenesis of Human Diffuse Large B Cell Lymphoma in Mice.

Pérez-Caro, M., Cobaleda, C., Piris, M. A., Melnick, A. M., & Snachez-Garcia, I. (2007) · Blood · doi:10.1182/blood.v110.11.3372.3372

Genomic organisation and expression of BCL6 in murine B-cell lymphomas

Qi, C., Hori, M., Coleman, A., Torrey, T. A., Taddesse-Heath, L., Ye, B. H., Chattopadhyay, S. K., Hartley, J. W., & Morse, H. C. (2000) · Leukemia Research · doi:10.1016/s0145-2126(00)00028-x · Cited by 25

Molekularne mechanizmy działania i patogenetyczna rola deregulacji BCL6 w chłoniaku rozlanym z dużych komórek B — implikacje kliniczne i terapeutyczne

Prusisz, W., Sewastianik, T., & Juszczyński, P. (2012) · Via Medica Journals

Generation of a Murine Model for c-MYC and BCL2 Co-expression B Cell Lymphomas

Cai, Z., Zhang, L., Cao, M., Wang, Y., Wang, F., Bian, W., Zhai, S., & Wang, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01007 · Cited by 2

The human BCL6 transgene promotes the development of lymphomas in the mouse

Baron, B. W., Anastasi, J., MONTAG, A. G., Huo, D., Baron, R. M., Karrison, T. G., Thirman, M. J., Subudhi, S. K., Chin, R., Felsher, D. W., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406138101 · Cited by 73